2025年4月21日，全球骨科巨头捷迈邦美Zimmer Biomet（纽约证券交易所代码：ZBH）宣布，已完成 对Paragon 28的收购，该交易价值 12亿美元 （合约87亿人民币）。Paragon 28拥有广泛的手术产品 和系统，涵盖足部和踝部所有主要领域，包括骨折和创伤、畸形矫正以及关节置换。 报名：首届全球骨科大会 | 议程更新 报名：首届全球心血管大会 | 重磅亮点 合作伙伴征集：2025全球手术机器人大会 # 收购分析 前情回顾 2025年1月，Zimmer Biomet同意收购Paragon 28， 将以 每股13美元 的价格收购Paragon 28的所有流 通股。 该交易包括每股13美元的现金预付款和每股高达1美元的或有价值权（CVR） ，与2026财年的具 体收入里程碑挂钩。 这一价格较Paragon周二收盘价12美元略有溢价；其股价在最近的10月份还曾跌破5美元。 Needham的分析人士在给投资者的报告中写道，他们长期以来一直认为Paragon 28 是潜在的被收购目标， 并对捷迈邦美支出的小幅溢价感到"惊讶"。分析人士预计，捷迈邦美可能会进行更多收购，收购方向可能超 出骨科领域范围。 ...

PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Paragon 28, Inc. (“Paragon”) (NYSE: FNA) shareholders. Click here for additional information: https://kaskelalaw.com/case/paragon-28/ On January 28, 2025, Paragon announced that it had agreed to be acquired by Zimmer Biomet Holdings, Inc. (“Zimmer”) at an upfront price of $13.00 per share in cash plus a non-tradable contingent value right (CVR) worth u ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40902 Paragon 28, Inc. (Exact name of Registrant as specified in its Charter) Delaware 27-3170186 (State or other j ...

Paragon 28, Inc. (FNA) shares ended the last trading session 8.3% higher at $12.99. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 16.2% gain over the past four weeks.Paragon 28 recorded a strong price rise on investors’ optimism surrounding an announcement by Zimmer Biomet to acquire all of the outstanding shares of Paragon 28. Zimmer Biomet agreed to buy Paragon 28 for an equity value of approximately $1.1 billi ...

Exhibit 99.2 Parac J.P. Morgan 43r Healthcare Con January 13, 20 Presenters: Albert DaCosta (CEO & Chadi Chahine (CFO and Supply Chain Operatior Forward Looking Statements Except for the historical information contained herein, the matters set forth in this presentation are forward-looking statements w "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Paragon 28's potential for foot and ankle patients; its estimated net revenue for full year 202 ...

Paragon 28, Inc. (FNA) closed the last trading session at $10.31, gaining 83.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.40 indicates a 39.7% upside potential.The average comprises five short-term price targets ranging from a low of $12 to a high of $20, with a standard deviation of $3.36. While the lowest estimate indicates an increase of 16.4% from the current price le ...

PHILADELPHIA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”). Investors that suffered losses from PARAGON 28 (NYSE: FNA) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn more about the l ...

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Paragon 28 securities during the ...

PHILADELPHIA, Nov. 23, 2024 (GLOBE NEWSWIRE) -- Nationally recognized law firm Berger Montague PC informs investors that a lawsuit was filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA) on behalf of purchasers of Paragon 28 securities between May 5, 2023 and September 20, 2024, inclusive (the “Class Period”). Investors that suffered losses from PARAGON 28 (NYSE: FNA) investments can follow the link below for more information regarding the lawsuit: CLICK HERE to learn more about the l ...

NEW YORK, Nov. 18, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Paragon 28, Inc. (NYSE: FNA) between May 5, 2023 and September 20, 2024, both dates inclusive (the “Class Period”), and those who purchased Paragon 28 call options or sold put options during the Class Period, of the November 29, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Paragon 28 securities during the ...